Workflow
lululemon(LULU) - 2026 Q2 - Earnings Call Presentation
2025-09-04 20:30
Financial Performance - Total revenue reached $2.5 billion, a 7% increase[2] - Diluted EPS was $3.10, a 2% decrease[2] - Total comparable sales increased by 1%[2] Segment Performance - Women's apparel revenue increased by 5%[7] - Men's apparel revenue increased by 6%[7] - Accessories and other revenue increased by 15%[7] - Store revenue increased by 3%[8] - Digital revenue increased by 9%[8] Market Performance - Americas revenue increased by 1%[9] - International revenue increased by 22%[9] Company Strategy - The company ended Q2 with 784 company-operated stores globally[9]
ICU Medical(ICUI) - 2025 FY - Earnings Call Presentation
2025-09-04 20:30
Company Overview - ICU Medical's 2024 revenues reached $2.35 billion[8] - The company's revenue mix includes 44% from consumables and 28% from systems pre-JV, which shifts to 52% and 33% post-JV respectively[6] - Vital Care accounts for 28% of revenue pre-JV and 16% post-JV[7] - Geographically, 64% of revenue comes from the US & Canada, and 36% from OUS post-JV[11] - Single-use consumables make up 88% of revenue, while hardware accounts for 12% post-JV[11] Financial Highlights - The company's diluted equity value is $3.2 billion, with a net debt of $1.0 billion, resulting in an enterprise value of $4.2 billion[11] Growth and Strategy - The industry is experiencing pump replacement cycle acceleration due to distinct circumstances[14] - The company is focused on improving its quality system and FDA warning letter remediation[37] - The company aims to achieve gross margin expansion, targeting 42-43% in the near-med term and 45% in the longer term[34] - The company is working towards a fully stable supply chain, production, and distribution network[37] - The company is focused on contract renewals of a significant portion of L-ICU US sales in late 2024[37]
Braze(BRZE) - 2026 Q2 - Earnings Call Presentation
2025-09-04 20:30
Financial Performance - Braze's quarterly revenue run rate is $720 million[3] - Q2 2026 revenue reached $1801 million, a 238% year-over-year increase and an 111% sequential growth[10, 14] - The GAAP gross margin was 677%, while the non-GAAP gross margin was 693%[10, 16] - The dollar-based net retention rate was 108%[4, 10, 18] - GAAP operating loss was $388 million, compared to a $280 million loss in the prior year quarter, while non-GAAP operating income was $60 million, compared to $42 million in the prior year quarter[10] - Net cash provided by operating activities was $70 million, compared to $310 million in the prior year quarter[10] - Free cash flow was $35 million, compared to $72 million in the prior year quarter[10, 23] Customer Growth - The customer base increased to 2,422 as of July 31, 2025, from 2,163 in the prior year quarter, representing a 12% year-over-year growth[4, 10, 20] Guidance - Q3 2026 revenue is projected to be between $1835 million and $1845 million, and full-year 2026 revenue is expected to be between $7170 million and $7200 million[29]
Prestige sumer Healthcare (PBH) - 2025 FY - Earnings Call Presentation
2025-09-04 16:45
Financial Performance & Strategy - FY25 revenues reached $1,137.8 million[69] - The company achieved a 5-year revenue CAGR of 34%[17,69] - Adjusted EPS 5-year CAGR was +88%[17] - Organic revenue 5-year CAGR was +24%[17,69] - Adjusted FY25 Free Cash Flow reached $243291 thousand[49,75] - Net leverage was significantly reduced to 24x[49] - The company anticipates approximately $1 billion total Free Cash Flow over the next four years[51] E-commerce & International Expansion - E-commerce as a percentage of net sales has increased +4x from approximately 4% in FY19 to approximately 16% in FY25[33] - International revenue accounts for approximately 16% of Prestige Net Sales in FY25[45] FY26 Outlook - Expected revenue for FY26 is projected to be between $1,100 to $1,115 million[59] - Projected FY26 Non-GAAP Free Cash Flow is $245 million[59,77]
The Toro pany(TTC) - 2025 Q3 - Earnings Call Presentation
2025-09-04 15:00
Financial Performance - The Toro Company's Q3 2025 net sales were $1,131.3 million, a decrease of 2.2% compared to $1,156.9 million in Q3 2024[25] - Adjusted diluted EPS for Q3 2025 was $1.24, a 5.1% increase from $1.18 in Q3 2024[25] - The company repurchased $90 million of its common stock during Q3 2025[6] - The company updated its full-year fiscal 2025 adjusted diluted EPS guidance to approximately $4.15[6] Segment Results - Professional segment net sales increased by 5.7%, from $880.9 million in Q3 2024 to $930.8 million in Q3 2025[27] - Professional segment earnings margin increased by 250 bps, from 18.8% in Q3 2024 to 21.3% in Q3 2025[27] - Residential segment net sales decreased by 27.9%, from $267.5 million in Q3 2024 to $192.8 million in Q3 2025[30] - Residential segment earnings margin decreased by 1030 bps, from 12.2% in Q3 2024 to 1.9% in Q3 2025[30] Cost Savings and Efficiency - The company's AMP initiative is expected to deliver at least $100 million in incremental annualized cost savings by fiscal 2027[22] - Approximately $4 million of run-rate savings were achieved in Q3 2025 through the AMP initiative[24] Tariff Mitigation - The company estimates fiscal 2025 tariff headwinds to be approximately $70 million, down from a prior estimate of approximately $90 million[7] - The company is on track to mitigate 100% of tariff headwinds for full-year 2025[9]
SAIC(SAIC) - 2026 Q2 - Earnings Call Presentation
2025-09-04 14:00
Financial Performance - Q2 FY26 - Revenue decreased from $1.818 billion in FY25 to $1.769 billion in FY26[13], a decrease of approximately 2.7% - Adjusted EBITDA increased from $170 million in FY25 to $185 million in FY26[14], representing an increase of approximately 8.8% - Adjusted Diluted EPS increased significantly from $2.05 in FY25 to $3.63 in FY26[15] - Free Cash Flow decreased from $241 million in FY25 to $150 million in FY26[16] Fiscal Year 2026 Guidance - Revenue guidance is revised downwards to $7.250 billion - $7.325 billion, compared to the prior guidance of $7.60 billion - $7.75 billion[19] - Organic growth is expected to be approximately -2% to -3%[19] - Adjusted EBITDA is projected to be $680 million - $690 million, with a margin of 9.3% - 9.5%[19] - Adjusted Diluted EPS is expected to be $9.40 - $9.60[19] - Free Cash Flow is projected to be greater than $550 million[19] Business Development - The company is navigating near-term revenue pressure due to a challenging environment for on-contract growth and new business award delays [5] - The company is implementing cost efficiency initiatives, including artificial intelligence, to drive greater efficiency and leverage investments [5]
Hyatt Hotels (H) 2025 Earnings Call Presentation
2025-09-04 14:00
General Information - Hyatt recently opened Park Hyatt Johannesburg in July 2025[1] - The presentation contains forward-looking statements subject to risks and uncertainties[2] Forward-Looking Statements Disclaimer - Actual results may differ materially from those expressed or implied due to various factors, including economic conditions, supply chain constraints, and geopolitical events[2] - The company is not obligated to update forward-looking statements[2]
John Wiley & Sons(WLY) - 2026 Q1 - Earnings Call Presentation
2025-09-04 14:00
First Quarter 2026 Earnings Review NON-GAAP FINANCIAL MEASURES Wiley provides non-GAAP financial measures and performance results such as: Management believes non-GAAP financial measures, which exclude the impact of restructuring charges and credits and certain other items, and the impact of divestitures and acquisitions provide a useful comparable basis to analyze operating results and earnings. See the reconciliations of non-GAAP financial measures and explanations of the uses of non-GAAP measures in the ...
Caleres(CAL) - 2026 Q2 - Earnings Call Presentation
2025-09-04 14:00
Financial Performance - Q2 2025 - Sales decreased to $659 million, a 3.6% decrease compared to $683 million in 2Q24[19, 16] - Adjusted Earnings Per Share (EPS) decreased to $0.35, compared to $0.85 in 2Q24[19, 16] - Gross margin was 43.4%, down 210 bps compared to 2Q24[19] - Inventory increased by 5% compared to 2Q24[19] - Adjusted EBITDA was $163 million[19] Segment Performance - **Famous Footwear:** Sales were $400 million, down 4.9% year-over-year, with comparable sales down 3.4%[26] Gross margin was 43.7%, down 130 bps year-over-year[26] - **Brand Portfolio:** Sales were $276 million, down 3.5% compared to 2Q24, including a $10 million impact from tariffs[21] Gross margin was 40.3%, down 240 bps compared to 2Q24[22] Outlook - Famous Footwear expects comparable sales to be up 1% in August, down low-single digits in September and October[30] - The Brand Portfolio expects Q3 gross margin to be down similar to Q2, with Q4 trends improving as mitigation strategies benefit[30] Strategic Initiatives - The company achieved $15 million in annualized, structural savings[14] - The company is partnering with a consulting firm to explore additional structural cost savings across the portfolio[30]
Duluth (DLTH) - 2026 Q2 - Earnings Call Presentation
2025-09-04 13:30
Financial Performance - Q2 2025 - Net income was $1.3 million, compared to a net loss of $2.0 million in the prior year's second quarter[10] - Reported EPS was $0.04, with adjusted EPS at $0.03, after adjusting for restructuring charges of $0.7 million (net of tax) and a tax valuation allowance of ($0.9) million[10] - Adjusted EBITDA increased by $1.5 million year-over-year to $12.0 million, representing 9.1% of net sales[10] - Inventory decreased by $20.7 million, a 12.2% reduction compared to the previous year[10] Balance Sheet and Liquidity - Cash and cash equivalents totaled $5.7 million, with net liquidity at $73.3 million[10] - Total debt stood at $32.5 million, resulting in a debt to capital ratio of 16.3%[17] Fiscal Year 2025 Outlook - The company is maintaining its fiscal year 2025 financial guidance, with an adjusted EBITDA range of $20 to $25 million[10]